[HTML][HTML] The epidemiology, risk profiling and diagnostic challenges of nonalcoholic fatty liver disease

U Iqbal, BJ Perumpail, D Akhtar, D Kim, A Ahmed - Medicines, 2019 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD) encompasses a wide spectrum of liver damage
from the more prevalent (75%–80%) and nonprogressive nonalcoholic fatty liver (NAFL) …

[HTML][HTML] Pathogenesis of insulin resistance and atherogenic dyslipidemia in nonalcoholic fatty liver disease

DH Akhtar, U Iqbal… - Journal of clinical and …, 2019 - ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
in the developed world, with a global prevalence of around 25%. NAFLD is considered to be …

[HTML][HTML] Chronic liver disease and silymarin: A biochemical and clinical review

SP Tighe, D Akhtar, U Iqbal… - Journal of clinical and …, 2020 - ncbi.nlm.nih.gov
Chronic liver disease (CLD) is an under-recognized epidemic that continues to increase in
prevalence and is a major health concern. Silymarin, the active compound of Silybum …

[HTML][HTML] The use of dupilumab in severe atopic dermatitis during pregnancy: a case report

NH Akhtar, T Khosravi-Hafshejani, D Akhtar… - Allergy, Asthma & …, 2022 - Springer
Background Atopic dermatitis is a common chronic skin disease that can occur in pregnancy.
Current treatments include topical and systemic glucocorticoids and cyclosporine. Presently…

Gender and racial differences in hospitalizations for primary biliary cholangitis in the USA

AC Adejumo, DH Akhtar, BB Dennis… - Digestive Diseases and …, 2021 - Springer
Background/Aim The prevalence, characteristics, burden and trends of primary biliary
cholangitis (PBC) hospitalizations in the USA remain unclear. Method We identified primary PBC …

[HTML][HTML] Safety and efficacy of Nitazoxanide-based regimen for the eradication of helicobacter pylori infection: a systematic review and meta-analysis

U Iqbal, HS Khara, D Akhtar, Y Hu… - Gastroenterology …, 2020 - ncbi.nlm.nih.gov
Background Helicobacter pylori (HP) is the most common cause of gastritis worldwide.
Clarithromycin-based triple therapy or bismuth-based quadruple therapy is usually considered …

Inhibition of GLI1 Expression by Targeting the CRD-BP–GLI1 mRNA Interaction Using a Specific Oligonucleotide

K Mehmood, D Akhtar, S Mackedenski, C Wang… - Molecular …, 2016 - ASPET
The stabilization of glioma-associated oncogene 1 (GLI1) mRNA by coding region determinant
binding protein (CRD-BP) through the Wnt/β-catenin signaling pathway is implicated in …

Rosai-Dorfman-Destombes disease of the pancreas: the great masquerader

D Akhtar, DR Owen, SF Murphy, SI Gan, LYC Chen - The Lancet, 2023 - thelancet.com
chemistry demonstrated the histiocytes were positive for CD68 and S100, and negative for
CD1a. The clinical presentation and histological findings were consistent with Rosai-Dorfman-…

The impact of chronic liver disease in patients receiving active pharmacological therapy for opioid use disorder: One-year findings from a prospective cohort study

BB Dennis, D Akhtar, G Cholankeril, D Kim… - Drug and Alcohol …, 2020 - Elsevier
Introduction Despite the demonstrated benefit of methadone, the incidence opioid-related
overdose, and its associated mortality continues to rise at an alarming rate. The impact of high …

Sex-specific risk factors and health disparity among hepatitis C positive patients receiving pharmacotherapy for opioid use disorder: findings from a propensity …

BB Dennis, LJ Martin, L Naji, D Akhtar… - Journal of addiction …, 2022 - journals.lww.com
Background The incidence of opioid-related fatality has reached unparalleled levels across
North America. Patients with comorbid hepatitis C virus (HCV) remain the most vulnerable …